Mark Sleeman

Mark Sleeman

Company: Regeneron Pharmaceuticals

Job title: Head of Obesity, Muscle & Metabolism Research

Seminars:

Prioritizing Quality Over Quantity in Weight Loss: Strategies for Preserving Muscle Mass in Obesity Treatment 10:30 am

Explore innovative therapeutic approaches that focus on maintaining muscle mass during weight loss, with insights into Regeneron’s cutting-edge research on musclepreserving antibodies Understand the metabolic benefits of muscle preservation in obesity management, including the dual-targeting strategies used to block muscle degradation pathwaysRead more

day: Conference Day One

Panel Discussion: Assessing the Obesity Landscape, Examining Areas of Improvement with Current Standards of Care to Define Best in Class & Future Directions 8:00 am

What is the benchmark with the current therapeutics on the market? Where are the shortfalls we can improve upon to improve the standard of care? What is the current unmet need for patients? What do patients actually want to see improved?Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.